NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Brain Cancer



New brain cancer study findings have been published by J. Kazmierska and colleagues



April 22nd, 2008

Researchers in Poznan, Poland conducted a study "To study the accuracy, specificity and sensitivity of the Naive Bayesian Classifier (NBC) in the assessment of individual risk of cancer relapse or progression after radiotherapy (RT). Data of 142 brain tumour patients irradiated from 2000 to 2005 were analyzed."

"Ninety-six attributes related to disease, patient and treatment were chosen. Attributes in binary form consisted of the training set for NBC learning. NBC calculated an individual conditional probability of being assigned to: relapse or progression (1), or no relapse or progression (0) group. Accuracy, attribute selection and quality of classifier were...


Source: Cancer Weekly (2008-04-22)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login